JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4417639
Title: Nt5c2 inhibitors useful for the treatment of chemotherapy resistant acute lymphoblastic leukemia
Patent ID: WO-2018067834-A1